UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 486

Sortiert nach

Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study

Osteoporosis international, 2018-01, Vol.29 (1), p.41-47

2018

Volltextzugriff (PDF)

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

The New England journal of medicine, 2009-08, Vol.361 (8), p.756-765

2009

Volltextzugriff (PDF)

prevalence of radiographic vertebral fractures in Latin American countries: the Latin American Vertebral Osteoporosis Study (LAVOS)

Osteoporosis international, 2009-02, Vol.20 (2), p.275-282

2009

Volltextzugriff (PDF)

Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status

Osteoporosis international, 2009-12, Vol.20 (12), p.2095-2104

2009

Volltextzugriff (PDF)

Retreatment with teriparatide: our experience in three patients with severe secondary osteoporosis

Osteoporosis international, 2017-04, Vol.28 (4), p.1491-1494

2017

Volltextzugriff (PDF)

Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3‐Year, Randomized, Placebo‐, and Active‐Controlled Clinical Trial

Journal of bone and mineral research, 2008-12, Vol.23 (12), p.1923-1934

2008

Volltextzugriff (PDF)

Bone microarchitecture in Rett syndrome and treatment with teriparatide: a case report

Osteoporosis international, 2016-09, Vol.27 (9), p.2873-2877

2016

Volltextzugriff (PDF)

Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial

Osteoporosis international, 2018-02, Vol.29 (2), p.323-328

2018

Volltextzugriff (PDF)

Effects of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] on Cortical Bone in Postmenopausal Women With Osteoporosis

Journal of bone and mineral research, 2003-03, Vol.18 (3), p.539-543

2003

Volltextzugriff (PDF)

Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis

Osteoporosis international, 2017-10, Vol.28 (10), p.2967-2973

2017

Volltextzugriff (PDF)

Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women

Journal of bone and mineral research, 2011-02, Vol.26 (2), p.397-404

2011

Volltextzugriff (PDF)

Evaluation of bone microarchitecture by high-resolution peripheral quantitative computed tomography (HR-pQCT) in hemodialysis patients

Osteoporosis international, 2012-10, Vol.23 (10), p.2543-2550

2012

Volltextzugriff (PDF)

Effects of teriparatide [rhPTH (1–34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women

Bone (New York, N.Y.), 2005-06, Vol.36 (6), p.948-958

2005

Volltextzugriff (PDF)

The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures

Osteoporosis international, 2012-08, Vol.23 (8), p.2141-2150

2012

Volltextzugriff (PDF)

Uniform stability for a semilinear non-homogeneous Timoshenko system with localized nonlinear damping

Zeitschrift für angewandte Mathematik und Physik, 2021-12, Vol.72 (6), Article 191

2021

Volltextzugriff (PDF)

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

The New England journal of medicine, 2001-05, Vol.344 (19), p.1434-1441

2001

Volltextzugriff (PDF)

Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data

Osteoporosis international, 2013-01, Vol.24 (1), p.293-299

2013

Volltextzugriff (PDF)

The vacuum cleft sign : an uncommon radiological sign

Osteoporosis international, 2005-10, Vol.16 (10), p.1210-1214

2005

Volltextzugriff (PDF)

Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet

Osteoporosis international, 2012-01, Vol.23 (1), p.267-276

2012

Volltextzugriff (PDF)

Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment : a meta-analysis

Osteoporosis international, 2006-11, Vol.17 (11), p.1630-1637

2006

Volltextzugriff (PDF)

Gender-Related Differences in the Relationship Between Densitometric Values of Whole-Body Bone Mineral Content and Lean Body Mass in Humans Between 2 and 87 Years of Age

Bone (New York, N.Y.), 1998-06, Vol.22 (6), p.683-690

1998

Volltextzugriff (PDF)

Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results

Osteoporosis international, 2008-07, Vol.19 (7), p.1039-1045

2008

Volltextzugriff (PDF)

Mechanical validation of a tomographic (pQCT) index for noninvasive estimation of rat femur bending strength

Bone (New York, N.Y.), 1996-02, Vol.18 (2), p.97-102

1996

Volltextzugriff (PDF)

Arzoxifene versus raloxifene: effect on bone and safety parameters in postmenopausal women with osteoporosis

Osteoporosis international, 2012-03, Vol.23 (3), p.1091-1101

2012

Volltextzugriff (PDF)

Bone mass in children: normative values for the 2-20-year-old population

Bone (New York, N.Y.), 1995-04, Vol.16 (4), p.393S-399S

1995

Volltextzugriff (PDF)

1 – 25 von 486

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(409)
Mit Volltextzugriff
(425)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

prevalence of radiographic vertebral fractures in Latin American countries: the Latin American Vertebral Osteoporosis Study (LAVOS)

Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status

Retreatment with teriparatide: our experience in three patients with severe secondary osteoporosis

Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3‐Year, Randomized, Placebo‐, and Active‐Controlled Clinical Trial

Bone microarchitecture in Rett syndrome and treatment with teriparatide: a case report

Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial

Effects of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] on Cortical Bone in Postmenopausal Women With Osteoporosis

Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis

Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women

Evaluation of bone microarchitecture by high-resolution peripheral quantitative computed tomography (HR-pQCT) in hemodialysis patients

Effects of teriparatide [rhPTH (1–34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women

The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures

Uniform stability for a semilinear non-homogeneous Timoshenko system with localized nonlinear damping

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data

The vacuum cleft sign : an uncommon radiological sign

Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet

Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment : a meta-analysis

Gender-Related Differences in the Relationship Between Densitometric Values of Whole-Body Bone Mineral Content and Lean Body Mass in Humans Between 2 and 87 Years of Age

Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results

Mechanical validation of a tomographic (pQCT) index for noninvasive estimation of rat femur bending strength

Arzoxifene versus raloxifene: effect on bone and safety parameters in postmenopausal women with osteoporosis

Bone mass in children: normative values for the 2-20-year-old population

Suchergebnisse filtern